Cargando…
Management of Sjogren’s Dry Eye Disease—Advances in Ocular Drug Delivery Offering a New Hope
Sjögren’s syndrome is a chronic and insidious autoimmune disease characterized by lymphocyte infiltration of exocrine glands. Patients typically present with dry eye, dry mouth, and other systemic manifestations. Currently, the available molecules and drug-delivery systems for the treatment of Sjögr...
Autores principales: | Wu, Kevin Y., Chen, Wei T., Chu-Bédard, Y-Kim, Patel, Gauri, Tran, Simon D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861012/ https://www.ncbi.nlm.nih.gov/pubmed/36678777 http://dx.doi.org/10.3390/pharmaceutics15010147 |
Ejemplares similares
-
An Overview of the Dry Eye Disease in Sjögren’s Syndrome Using Our Current Molecular Understanding
por: Wu, Kevin Y., et al.
Publicado: (2023) -
Interferons and Dry Eye in Sjögren’s Syndrome
por: Ogawa, Yoko, et al.
Publicado: (2018) -
Concurrent primary Sjögren's syndrome and isolated ocular sarcoidosis presenting with bilateral corneal scarring and dry eye
por: Cui, David, et al.
Publicado: (2020) -
Resveratrol for dry eye disease – Hope or Hype?
por: Shetty, Rohit, et al.
Publicado: (2023) -
Tear film microbiome in Sjogren’s and non-Sjogren’s aqueous deficiency dry eye
por: Pal, Spandita, et al.
Publicado: (2023)